Toward safer prescribing: evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea

S. J. Kim, K. T. Han, H. G. Kang, E. C. Park

Research output: Contribution to journalArticle

Abstract

Objectives: This study aimed to evaluate the effect of the prospective drug utilization review (DUR) system introduced in Korea in December 2010 as a real-time method to improve patient safety, in terms of changes in prescribing practices, adverse drug events (ADEs), and ADE-related healthcare expenditure, using non-steroidal anti-inflammatory drugs (NSAIDs) and their common ADEs as a guide. Study design: We used an interrupted time-series study design using generalized estimating equations to evaluate changes in prescription rate and ADE-related healthcare expenditure. Cox regression analysis was used to evaluate the probability of NSAID-associated ADEs. Methods: A total of 154,585 outpatients with musculoskeletal or connective tissue disorders, without pre-existing gastric bleeding or ulcers were included in this study. The primary outcome was the level and trend change in prescription rate, drug–drug interactions, coprescribed gastro-protective drugs, and defined daily dose (DDD) of NSAIDs. The secondary outcome was the probability of ADEs and changes in ADE-related healthcare expenditure. Results: There was a significant trend change after introducing the DUR system in terms of drug–drug interactions (−3.6%) and coprescribed gastro-protective drugs (+0.6%). The mean DDD of NSAIDs increased by 0.2. The probability of ADEs decreased overall (−1.7%) and in the high-risk group (age ≥65 years; −9.6%); however, only the latter was significant. There was no significant trend or level change in ADE-related health expenditure. Conclusions: The introduction of the DUR system was associated with more efficient prescribing, including a reduction in drug–drug interactions and an increase in the use of gastro-protective drugs. The system had a positive effect on patient outcome but was not associated with reduced ADE-related costs. Further studies are needed to evaluate the long-term effects of the DUR system in Korea.

Original languageEnglish
Pages (from-to)128-136
Number of pages9
JournalPublic Health
Volume163
DOIs
Publication statusPublished - 2018 Oct

Fingerprint

Drug Utilization Review
Inappropriate Prescribing
Republic of Korea
Health Expenditures
Drug-Related Side Effects and Adverse Reactions
Protective Agents
Anti-Inflammatory Agents
Korea
Delivery of Health Care
Pharmaceutical Preparations
Prescriptions
Preexisting Condition Coverage
Patient Safety
Connective Tissue
Ulcer
Stomach
Outpatients
Age Groups

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

@article{c061f90dc24c4353a3a048d0755f8371,
title = "Toward safer prescribing: evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea",
abstract = "Objectives: This study aimed to evaluate the effect of the prospective drug utilization review (DUR) system introduced in Korea in December 2010 as a real-time method to improve patient safety, in terms of changes in prescribing practices, adverse drug events (ADEs), and ADE-related healthcare expenditure, using non-steroidal anti-inflammatory drugs (NSAIDs) and their common ADEs as a guide. Study design: We used an interrupted time-series study design using generalized estimating equations to evaluate changes in prescription rate and ADE-related healthcare expenditure. Cox regression analysis was used to evaluate the probability of NSAID-associated ADEs. Methods: A total of 154,585 outpatients with musculoskeletal or connective tissue disorders, without pre-existing gastric bleeding or ulcers were included in this study. The primary outcome was the level and trend change in prescription rate, drug–drug interactions, coprescribed gastro-protective drugs, and defined daily dose (DDD) of NSAIDs. The secondary outcome was the probability of ADEs and changes in ADE-related healthcare expenditure. Results: There was a significant trend change after introducing the DUR system in terms of drug–drug interactions (−3.6{\%}) and coprescribed gastro-protective drugs (+0.6{\%}). The mean DDD of NSAIDs increased by 0.2. The probability of ADEs decreased overall (−1.7{\%}) and in the high-risk group (age ≥65 years; −9.6{\%}); however, only the latter was significant. There was no significant trend or level change in ADE-related health expenditure. Conclusions: The introduction of the DUR system was associated with more efficient prescribing, including a reduction in drug–drug interactions and an increase in the use of gastro-protective drugs. The system had a positive effect on patient outcome but was not associated with reduced ADE-related costs. Further studies are needed to evaluate the long-term effects of the DUR system in Korea.",
author = "Kim, {S. J.} and Han, {K. T.} and Kang, {H. G.} and Park, {E. C.}",
year = "2018",
month = "10",
doi = "10.1016/j.puhe.2018.06.009",
language = "English",
volume = "163",
pages = "128--136",
journal = "Public Health",
issn = "0033-3506",
publisher = "Elsevier",

}

TY - JOUR

T1 - Toward safer prescribing

T2 - evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea

AU - Kim, S. J.

AU - Han, K. T.

AU - Kang, H. G.

AU - Park, E. C.

PY - 2018/10

Y1 - 2018/10

N2 - Objectives: This study aimed to evaluate the effect of the prospective drug utilization review (DUR) system introduced in Korea in December 2010 as a real-time method to improve patient safety, in terms of changes in prescribing practices, adverse drug events (ADEs), and ADE-related healthcare expenditure, using non-steroidal anti-inflammatory drugs (NSAIDs) and their common ADEs as a guide. Study design: We used an interrupted time-series study design using generalized estimating equations to evaluate changes in prescription rate and ADE-related healthcare expenditure. Cox regression analysis was used to evaluate the probability of NSAID-associated ADEs. Methods: A total of 154,585 outpatients with musculoskeletal or connective tissue disorders, without pre-existing gastric bleeding or ulcers were included in this study. The primary outcome was the level and trend change in prescription rate, drug–drug interactions, coprescribed gastro-protective drugs, and defined daily dose (DDD) of NSAIDs. The secondary outcome was the probability of ADEs and changes in ADE-related healthcare expenditure. Results: There was a significant trend change after introducing the DUR system in terms of drug–drug interactions (−3.6%) and coprescribed gastro-protective drugs (+0.6%). The mean DDD of NSAIDs increased by 0.2. The probability of ADEs decreased overall (−1.7%) and in the high-risk group (age ≥65 years; −9.6%); however, only the latter was significant. There was no significant trend or level change in ADE-related health expenditure. Conclusions: The introduction of the DUR system was associated with more efficient prescribing, including a reduction in drug–drug interactions and an increase in the use of gastro-protective drugs. The system had a positive effect on patient outcome but was not associated with reduced ADE-related costs. Further studies are needed to evaluate the long-term effects of the DUR system in Korea.

AB - Objectives: This study aimed to evaluate the effect of the prospective drug utilization review (DUR) system introduced in Korea in December 2010 as a real-time method to improve patient safety, in terms of changes in prescribing practices, adverse drug events (ADEs), and ADE-related healthcare expenditure, using non-steroidal anti-inflammatory drugs (NSAIDs) and their common ADEs as a guide. Study design: We used an interrupted time-series study design using generalized estimating equations to evaluate changes in prescription rate and ADE-related healthcare expenditure. Cox regression analysis was used to evaluate the probability of NSAID-associated ADEs. Methods: A total of 154,585 outpatients with musculoskeletal or connective tissue disorders, without pre-existing gastric bleeding or ulcers were included in this study. The primary outcome was the level and trend change in prescription rate, drug–drug interactions, coprescribed gastro-protective drugs, and defined daily dose (DDD) of NSAIDs. The secondary outcome was the probability of ADEs and changes in ADE-related healthcare expenditure. Results: There was a significant trend change after introducing the DUR system in terms of drug–drug interactions (−3.6%) and coprescribed gastro-protective drugs (+0.6%). The mean DDD of NSAIDs increased by 0.2. The probability of ADEs decreased overall (−1.7%) and in the high-risk group (age ≥65 years; −9.6%); however, only the latter was significant. There was no significant trend or level change in ADE-related health expenditure. Conclusions: The introduction of the DUR system was associated with more efficient prescribing, including a reduction in drug–drug interactions and an increase in the use of gastro-protective drugs. The system had a positive effect on patient outcome but was not associated with reduced ADE-related costs. Further studies are needed to evaluate the long-term effects of the DUR system in Korea.

UR - http://www.scopus.com/inward/record.url?scp=85051962030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051962030&partnerID=8YFLogxK

U2 - 10.1016/j.puhe.2018.06.009

DO - 10.1016/j.puhe.2018.06.009

M3 - Article

C2 - 30145461

AN - SCOPUS:85051962030

VL - 163

SP - 128

EP - 136

JO - Public Health

JF - Public Health

SN - 0033-3506

ER -